Menu Close

Report  |  November 2023

An Economic Assessment of the FDA Proposal Rule: “Medication Guides: Patient Medication Information”

By Nam D. Pham, Ph.D. and Mary Donovan

An assessment of an FDA proposed rule requiring drug manufacturers to create a new type of Medication Guides, referred to as Patient Medication Information (PMI), for prescription drug, biological, and blood transfusion products.